stockrowTeleflex Incorporated
TFX Healthcare Medical Instruments & Supplies
Teleflex Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $2.0 billion, up 17.2% from fiscal 2024.
- Revenue
- +28.9%
- EPS
- −17.3%
- Free cash flow
- +220.1%
- Total debt
- +47.7%
Quarter to June 2026, against a year earlier
Follow TFX
Alert me
Teleflex Incorporated (TFX) Revenue
Teleflex Incorporated's revenue for fiscal 2025 was $2.0B, up 17.2% from $1.7B in fiscal 2024. Over the twelve months to 30 June 2026 it was $2.3B. Over the past ten years it has ranged from $1.7B (fiscal 2024) to $2.8B (fiscal 2021); the current reading is higher than 45% of that period. Teleflex Incorporated ranks 17th of 47 Medical Instruments & Supplies companies by revenue.
Revenue, annual
Embed this chart
Annual newest first
| Period | Revenue | Change |
|---|---|---|
| FY2025 | $2.0B | 17.25% |
| FY2024 | $1.7B | (0.75%) |
| FY2023 | $1.7B | (38.65%) |
| FY2022 | $2.8B | (0.66%) |
| FY2021 | $2.8B | 10.74% |
| FY2020 | $2.5B | (2.24%) |
| FY2019 | $2.6B | 6.00% |
| FY2018 | $2.4B | 14.07% |
| FY2017 | $2.1B | 14.90% |
| FY2016 | $1.9B | 3.22% |
Quarterly newest first
| Period | Revenue | Change |
|---|---|---|
| Jun 2026 | $570.3M | 4.03% |
| Mar 2026 | $548.3M | (3.64%) |
| Dec 2025 | $569.0M | 0.36% |
| Sep 2025 | $566.9M | 28.12% |
| 42 more quarters | Free account |
Against its own ten years
Revenue against peers
| Company | Revenue |
|---|---|
| AVTR Avantor, Inc. compare | $6.6B |
| BLCO Bausch + Lomb Corporation compare | $5.4B |
| ATR AptarGroup, Inc. compare | $4.0B |
| MMED MiniMed Group, Inc. compare | $3.0B |
| NVST Envista Holdings Corporation compare | $2.9B |
| TFX Teleflex Incorporated | $2.3B |
| ICUI ICU Medical, Inc. compare | $2.2B |
| MMSI Merit Medical Systems, Inc. compare | $1.6B |
| PLSE Pulse Biosciences, Inc compare | $1.5M |
What Revenue is
Revenue tells an investor how much a company brought in from selling its goods and services over a period, before any costs are taken out.
Reported line item
More on TFX
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement